Arshad Siddiqui
Algemeen Directeur bij Paraza Pharma, Inc.
Profiel
Arshad Siddiqui is the founder of Paraza Pharma, Inc. which he founded in 2011 and where he holds the title of President & Chief Executive Officer.
He is currently the Director at Egenix, Inc. where he started in 2013.
Dr. Siddiqui holds a doctorate degree from The University of Waterloo.
Actieve functies van Arshad Siddiqui
| Bedrijven | Functie | Begin |
|---|---|---|
Egenix, Inc.
 Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | Directeur/Bestuurslid | 21-05-2013 |
| Paraza Pharma, Inc. | Algemeen Directeur | 01-01-2011 |
Opleiding van Arshad Siddiqui
| The University of Waterloo | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Egenix, Inc.
Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | Health Technology |
| Paraza Pharma, Inc. |
